Cargando…

Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study

The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Galiniak, Sabina, Podgórski, Rafał, Rachel, Marta, Mazur, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586927/
https://www.ncbi.nlm.nih.gov/pubmed/36271282
http://dx.doi.org/10.1038/s41598-022-21851-8
_version_ 1784813793007632384
author Galiniak, Sabina
Podgórski, Rafał
Rachel, Marta
Mazur, Artur
author_facet Galiniak, Sabina
Podgórski, Rafał
Rachel, Marta
Mazur, Artur
author_sort Galiniak, Sabina
collection PubMed
description The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF.
format Online
Article
Text
id pubmed-9586927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95869272022-10-23 Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study Galiniak, Sabina Podgórski, Rafał Rachel, Marta Mazur, Artur Sci Rep Article The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF. Nature Publishing Group UK 2022-10-21 /pmc/articles/PMC9586927/ /pubmed/36271282 http://dx.doi.org/10.1038/s41598-022-21851-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Galiniak, Sabina
Podgórski, Rafał
Rachel, Marta
Mazur, Artur
Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_full Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_fullStr Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_full_unstemmed Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_short Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_sort serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586927/
https://www.ncbi.nlm.nih.gov/pubmed/36271282
http://dx.doi.org/10.1038/s41598-022-21851-8
work_keys_str_mv AT galiniaksabina serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT podgorskirafał serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT rachelmarta serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT mazurartur serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy